Evidence map›Paper›PMID 39138432›Full record

ArticleBMC geriatrics2024

MFI-11 in Chinese elderly esophageal cancer patients with postoperative adverse outcomes.

Xiu Chen, Yan Dang, Qi Zhang, Yuhang Ma, Long Yao, Hanlin Wang, Junrui Xu, Yuefeng Xu, Renquan Zhang

Abstract read
In one paragraph

Article in BMC geriatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiu Chen *Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Yan Dang *Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Qi ZhangDepartment of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Yuhang MaDepartment of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Long YaoDepartment of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Hanlin WangDepartment of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Junrui XuDepartment of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Yuefeng XuDepartment of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China.
Renquan ZhangDepartment of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China. zrqahmu@163.com.

Funding

Natural Science Foundation of Anhui Province 1808085QH271This study was supported by grants from Natural Science Foundation of Anhui Universities KJ2019ZD22
6 · The paper itself

Abstract

backgroundFrailty becomes more pronounced with advancing age, tightly intertwined with adverse clinical outcomes. Across diverse medical disciplines, frailty is now universally recognized as not only a risk factor but also a predictive indicator for unfavorable clinical prognosis.

methodsThis study was a retrospective cohort study that included clinical data from patients (aged ≥ 65 years) with esophageal cancer treated surgically at the First Affiliated Hospital of Anhui Medical University in 2021. For each patient, we calculated their 11-index modified frailty index(mFI-11) scores and categorized the patients into a frailty group (mFI-11hign) and a non-frailty group (mFI-11low) based on the optimal grouping cutoff value of 0.27 from a previous study. The primary study index was the incidence of postoperative pulmonary infection, arrhythmia, anastomotic fistula, chylothorax, and electrolyte disturbance complications. Secondary study indicators included postoperative ICU stay, total hospitalization time, readmission rate within 30 days of discharge, and mortality within 30 days after surgery. We performed univariate and multivariate analyses to assess the association between mFI-11 and adverse outcomes as well as postoperative complications.

resultsFive hundred and fifteen patients were included, including 64.9% (334/515) in the non-frailty group and 35.1% (181/515) in the frailty group. Comparing postoperative complication rates between the two groups revealed lower incidences of postoperative anastomotic fistula (21.5% vs. 4.5%), chylothorax (16.0% vs. 2.1%), cardiac arrhythmia (61.9% vs. 9.9%), pulmonary infections (85.1% vs. 26.6%), and electrolyte disturbance (84.5% vs. 15.0%) in patients of the non-frailty group was lower than that in the frailty group (p < 0.05). mFI-11 showed better prognostic results in predicting postoperative complications. anastomotic fistula (area under the ROC curve AUROC = 0.707), chylothorax (area under the ROC curve AUROC = 0.744), pulmonary infection (area under the ROC curve AUROC = 0.767), arrhythmia (area under the ROC curve AUROC = 0.793), electrolyte disturbance (area under the ROC curve AUROC = 0.832), and admission to ICU (area under the ROC curve AUROC = 0.700).

conclusionPreoperative frail elderly patients with esophageal cancer have a high rate of postoperative complications. mFI-11 can be used as an objective indicator for identifying elderly patients at risk for esophageal cancer.

Indexed as

Esophageal NeoplasmsPostoperative ComplicationsAgedAged, 80 and overChinaEast Asian PeopleEsophagectomyFemaleFrail ElderlyFrailtyGeriatric AssessmentHumansMalePrognosisRetrospective StudiesRisk FactorsElderlyFrailtymFI-11Postoperative complicationsRadical surgery for esophageal cancer

Identifiers

PMID39138432
PMCPMC11323644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.